{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:24:44Z","timestamp":1793118284461,"version":"4.5.0"},"reference-count":16,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Larotrectinib is a highly selective tropomyosin receptor kinase (TRK) inhibitor with efficacy in children with TRK fusion tumors. We evaluated patient outcomes after elective discontinuation of larotrectinib in the absence of disease progression in a protocol-defined wait-and-see subset analysis of eligible patients where treatment resumption with larotrectinib was allowed if disease progressed. We also assessed the safety and efficacy of larotrectinib in all pediatric patients with sarcoma. This cohort included 91 patients (younger than 18 years) from two clinical trials: infantile fibrosarcoma (49), other soft tissue sarcomas or related mesenchymal tumors (41), and bone sarcoma (1). Treatment-related adverse events were of maximum grade 1 or 2 in 25% and 25% of patients, respectively. The overall response rate was 87% (95% CI, 78 to 93). In the wait-and-see analysis, 47 patients discontinued larotrectinib. Median time from discontinuation to disease progression was not reached. Sixteen patients had tumor progression during the wait-and-see period. All 16 patients resumed larotrectinib, and 15 (94%) achieved disease control, with 11 objective responses. Larotrectinib continues to demonstrate durable responses with favorable safety in children with TRK fusion sarcomas. Treatment discontinuation is feasible in select patients with objective response and clinical benefit noted in those who have disease progression after elective treatment discontinuation.<\/jats:p>","DOI":"10.1200\/jco.24.00848","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:59:08Z","timestamp":1738011548000},"page":"1180-1187","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":17,"title":["Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors"],"prefix":"10.1200","volume":"43","clinical-trial-number":[{"clinical-trial-number":"nct02637687","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02576431","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7790-0777","authenticated-orcid":true,"given":"Leo","family":"Mascarenhas","sequence":"first","affiliation":[{"name":"Cedars Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0882-738X","authenticated-orcid":true,"given":"Steven G.","family":"DuBois","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children's Cancer and Blood Disorders Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7610-9932","authenticated-orcid":true,"given":"Catherine M.","family":"Albert","sequence":"additional","affiliation":[{"name":"Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-3153","authenticated-orcid":true,"given":"Stefan","family":"Bielack","sequence":"additional","affiliation":[{"name":"P\u00e4diatrie 5 (Onkologie, H\u00e4matologie, Immunologie), Zentrum f\u00fcr Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Klinikum Stuttgart\u2014Olgahospital, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-139X","authenticated-orcid":true,"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[{"name":"SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Federman","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-3643","authenticated-orcid":true,"given":"Birgit","family":"Geoerger","sequence":"additional","affiliation":[{"name":"Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, INSERM U1015, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramamoorthy","family":"Nagasubramanian","sequence":"additional","affiliation":[{"name":"Nemours Children's Hospital, Orlando, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-3476","authenticated-orcid":true,"given":"Yizhou","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-7997","authenticated-orcid":true,"given":"Julia","family":"Chisholm","sequence":"additional","affiliation":[{"name":"Children and Young Peoples Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-9624","authenticated-orcid":true,"given":"Soledad","family":"Gallego Melcon","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology, Vall d\u2019Hebron Children's Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Goto","sequence":"additional","affiliation":[{"name":"Kanagawa Children's Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-1108","authenticated-orcid":true,"given":"Daniel A.","family":"Morgenstern","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children and University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac","family":"Owens","sequence":"additional","affiliation":[{"name":"Department of Haemato-Oncology, Our Lady's Children's Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-3979","authenticated-orcid":true,"given":"Alberto S.","family":"Pappo","sequence":"additional","affiliation":[{"name":"St Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Perreault","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, CHU Sainte Justine, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-1201","authenticated-orcid":true,"given":"Johannes H.","family":"Schulte","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2516-2965","authenticated-orcid":false,"given":"Neerav","family":"Shukla","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-8268","authenticated-orcid":true,"given":"Christian Michel","family":"Zwaan","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Centre, Utrecht, the Netherlands"},{"name":"Erasmus MC, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Neu","sequence":"additional","affiliation":[{"name":"Chrestos Concept GmbH &amp; Co, KG, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Bernard-Gauthier","sequence":"additional","affiliation":[{"name":"Bayer Pharmaceuticals, Inc., Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"De La Cuesta","sequence":"additional","affiliation":[{"name":"Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5274-910X","authenticated-orcid":true,"given":"Cornelis M.","family":"van Tilburg","sequence":"additional","affiliation":[{"name":"Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany"},{"name":"Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany"},{"name":"Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"National Center f\u00fcr Tumor Disease (NCT), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8497-3138","authenticated-orcid":true,"given":"Theodore W.","family":"Laetsch","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia\/University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_11_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001203"},{"key":"e_1_3_11_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714448"},{"key":"e_1_3_11_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz383"},{"key":"e_1_3_11_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0113-0"},{"key":"e_1_3_11_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2023.2236305"},{"key":"e_1_3_11_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz282"},{"key":"e_1_3_11_8_2","unstructured":"Bayer HealthCare Pharmaceuticals Inc: VITRAKVI prescribing information 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/210861s008lbl.pdf"},{"key":"e_1_3_11_9_2","unstructured":"Bayer AG: VITRAKVI summary of product characteristics 2023. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vitrakvi-epar-product-information_en.pdf"},{"key":"e_1_3_11_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30856-3"},{"key":"e_1_3_11_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30119-0"},{"key":"e_1_3_11_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31701"},{"key":"e_1_3_11_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.06.028"},{"key":"e_1_3_11_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01854"},{"key":"e_1_3_11_15_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0114"},{"key":"e_1_3_11_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103006"},{"key":"e_1_3_11_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/M22-1460"}],"updated-by":[{"DOI":"10.1200\/jco-25-00252","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000}},{"DOI":"10.1200\/jco-25-00353","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000}}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.24.00848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T16:48:29Z","timestamp":1750438109000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.24.00848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1200\/JCO.24.00848"],"URL":"https:\/\/doi.org\/10.1200\/jco.24.00848","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}